CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Foreign Currency Contract, Asset, Fair Value Disclosure
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Foreign Currency Contract, Asset, Fair Value Disclosure of $15.00 thousand as of 2015-12-26, per its 10-K filed 2017-02-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:ForeignCurrencyContractAssetFairValueDisclosure · last filed 2017-02-14
- 2015-12-26: Foreign Currency Contract, Asset, Fair Value Disclosure $15.00K.
- 2015-09-26: Foreign Currency Contract, Asset, Fair Value Disclosure $16.00K.
| Period end | Foreign Currency Contract, Asset, Fair Value Disclosure |
|---|---|
| 2015-12-26 | $15.00K 10-K · filed 2017-02-14 |
| 2015-09-26 | $16.00K 10-Q · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |